B., V. (2022) “A REVIEW ON THE DEVELOPMENT OF FAVIPRAVIR AGAINST SARS COV 2 INFECTION”, International Journal of Current Pharmaceutical Research, 14(2), pp. 11–14. doi: 10.22159/ijcpr.2022v14i2.1957.